Cisplatin-based chronotherapy for advanced non-small cell lung cancer patients: a randomized controlled study and its pharmacokinetics analysis-Reference-Cited by-同舟云学术

Cisplatin-based chronotherapy for advanced non-small cell lung cancer patients: a randomized controlled study and its pharmacokinetics analysis

Published:2015-06-21 Issue:3 Volume:76 Page:651-655
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Li Jie,Chen Rong,Ji Mei,Zou Su-lan,Zhu Li-na

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-015-2804-x.pdf

Reference31 articles.

1. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA (2008) Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 83:584–594

2. Brodowicz T, Krzakowski M, Zwitter M, Tzekova V, Ramlau R, Ghilezan N (2006) Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial. Lung Cancer 52:155–163

3. Cappuzzo F, Ciuleanu T, Stelmakh L, Cicenas S, Szczesna A, Juhasz E (2010) Erlotinib as maintenance treatment in advanced non-small cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study. Lancet Oncol 11:521–529

4. Nation Comprehensive Cancer Network (2013) Non–small cell lung cancer (version 2.2014). Available: http://www.nccn.org/professionals/physician_gls/pdf/nscl.Pdf . Accessed 21 Jan 2014

5. Azzoli CG, Temin S, Giaccone G (2012) 2011 focused update of 2009 American Society of Clinical Oncology clinical practice guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Oncol Pract/Am Soc Clin Oncol 8:63–66

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of circadian clock-related immunological prognostic index and molecular subtypes in prostate cancer;Discover Oncology;2024-09-11

2. Efficacy on symptoms and mortality day vs. night administration of EGFR-TKIs for advanced non-small cell lung cancer;Supportive Care in Cancer;2024-09-09

3. Quantification of circadian rhythms in mammalian lung tissue snapshot data;Scientific Reports;2024-07-14

4. Clinical analysis of the efficacy of radiation therapy for primary high-grade gliomas guided by biological rhythms;Translational Oncology;2024-07

5. Circadian Regulation of Drug Responses: Toward Sex-Specific and Personalized Chronotherapy;Annual Review of Pharmacology and Toxicology;2024-01-23